Athene Stock Forecast, Price & News

Athene's stock was trading at $31.16 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ATH stock has increased by 14.2% and is now trading at $35.59.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Athene in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Athene.

Athene is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Athene.

Athene Holding Ltd (NYSE:ATH) released its quarterly earnings results on Wednesday, August, 5th. The insurance provider reported $2.49 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.90 by $0.59. The insurance provider earned $1.34 billion during the quarter, compared to analyst estimates of $940.68 million. Athene had a net margin of 13.50% and a return on equity of 7.93%. The firm's revenue was up 13.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.95 earnings per share.
View Athene's earnings history.

8 Wall Street analysts have issued 12-month price objectives for Athene's shares. Their forecasts range from $34.00 to $72.00. On average, they anticipate Athene's share price to reach $44.75 in the next year. This suggests a possible upside of 25.7% from the stock's current price.
View analysts' price targets for Athene.

Athene saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 10,690,000 shares, an increase of 19.7% from the August 15th total of 8,930,000 shares. Based on an average daily trading volume, of 1,810,000 shares, the short-interest ratio is presently 5.9 days. Approximately 8.1% of the company's stock are sold short.
View Athene's Short Interest.

Some companies that are related to Athene include Prudential Financial (PRU), SWISS RE LTD/S (SSREY), AVIVA PLC/ADR (AVVIY), Legal & General Group (LGEN), SONY FINL HOLDI/ADR (SNYFY), Globe Life (GL), AEGON (AEG), Reinsurance Group of America (RGA), Lincoln National (LNC), Voya Financial (VOYA), Scor (SCRYY), Primerica (PRI), Brighthouse Financial (BHF), American Equity Investment Life (AEL) and American National Insurance (ANAT).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include Docusign (DOCU), Alibaba Group (BABA), Micron Technology (MU), AT&T (T), Intel (INTC), Visa (V), JD.Com (JD), Okta (OKTA), Slack (WORK) and AbbVie (ABBV).

(ATH) raised $952 million in an initial public offering on Friday, December 9th 2016. The company issued 23,800,000 shares at $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities acted as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Athene's stock is owned by a number of institutional and retail investors. Top institutional investors include Apollo Management Holdings L.P. (28.43%), Vanguard Group Inc. (8.24%), Goldman Sachs Group Inc. (3.91%), Assenagon Asset Management S.A. (0.75%), Ensign Peak Advisors Inc (0.44%) and Nuveen Asset Management LLC (0.42%). Company insiders that own Athene stock include Frank Lauren Gillis, Grant Kvalheim, James Richard Belardi, Lawrence Ruisi, Marc A Beilinson, Martin P Klein and Robert L Borden.
View institutional ownership trends for Athene.

ATH stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Man Group plc, Russell Investments Group Ltd., Robeco Institutional Asset Management B.V., Nuveen Asset Management LLC, FMR LLC, FMR LLC, and Bank of America Corp DE. Company insiders that have sold Athene company stock in the last year include Frank Lauren Gillis, Lawrence Ruisi, and Robert L Borden.
View insider buying and selling activity for Athene.

ATH stock was purchased by a variety of institutional investors in the last quarter, including Apollo Management Holdings L.P., Goldman Sachs Group Inc., Assenagon Asset Management S.A., Vanguard Group Inc., MUFG Securities EMEA plc, Balyasny Asset Management LLC, Clark Capital Management Group Inc., and Bank of Nova Scotia. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi, Marc A Beilinson, and Martin P Klein.
View insider buying and selling activity for Athene.

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ATH stock can currently be purchased for approximately $35.59.

Athene has a market capitalization of $6.91 billion and generates $16.26 billion in revenue each year. The insurance provider earns $2.17 billion in net income (profit) each year or $6.94 on an earnings per share basis. Athene employs 1,325 workers across the globe.

The official website for Athene is www.athene.com.

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at 441-279-8400 or via email at [email protected]